Galectin-1 attenuates astrogliosis-associated injuries and improves recovery of rats following focal cerebral ischemia

Journal of Neurochemistry

Volumn 116, Issue 2, 2011, Pages 217-226

  Qu, Wen Sheng ^a   Wang, Yi Hui ^a   Ma, Jun Fang ^a   Tian, Dai Shi ^a   Zhang, Qiang ^a   Pan, Deng Ji ^a   Yu, Zhi Yuan ^a   Xie, Min Jie ^a   Wang, Jian Ping ^b   Wang, Wei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

astrogliosis; cerebral ischemia; function recovery; galectin 1; neuronal apoptosis

Indexed keywords

GALECTIN 1; INTERLEUKIN 1BETA; LACTOSE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN FUNCTION; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; ASTROCYTES; BRAIN ISCHEMIA; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GALECTIN 1; GLIOSIS; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; UP-REGULATION;

RATTUS;

EID: 78650699630     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.07095.x     Document Type: Article

References (59)

1. Abbott N. J., (2002) Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat. 200, 629-638.
2. Amano M., Galvan M., He J., and, Baum L. G., (2003) The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death. J. Biol. Chem. 278, 7469-7475.
3. Bauer J., Elger C. E., Hans V. H., Schramm J., Urbach H., Lassmann H., and, Bien C. G., (2007) Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann. Neurol. 62, 67-80.
4. Baum L. G., Pang M., Perillo N. L., Wu T., Delegeane A., Uittenbogaart C. H., Fukuda M., and, Seilhamer J. J., (1995) Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. J. Exp. Med. 181, 877-887.
5. Binder D. K., and, Steinhauser C., (2006) Functional changes in astroglial cells in epilepsy. Glia 54, 358-368.
6. Cheung W. M., Wang C. K., Kuo J. S., and, Lin T. N., (1999) Changes in the level of glial fibrillary acidic protein (GFAP) after mild and severe focal cerebral ischemia. Chin. J. Physiol. 42, 227-235.
7. Di Giovanni S., Movsesyan V., Ahmed F., Cernak I., Schinelli S., Stoica B., and, Faden A. I., (2005) Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc. Natl Acad. Sci. USA 102, 8333-8338.
8. Dietrich W. D., Prado R., Pravia C., Zhao W., Ginsberg M. D., and, Watson B. D., (1999) Delayed hypovolemic hypotension exacerbates the hemodynamic and histopathologic consequences of thromboembolic stroke in rats. J. Cereb. Blood Flow Metab. 19, 918-926.
9. Dunn S. L., Young E. A., Hall M. D., and, McNulty S., (2002) Activation of astrocyte intracellular signaling pathways by interleukin-1 in rat primary striatal cultures. Glia 37, 31-42.
10. Escartin C., Valette J., Lebon V., and, Bonvento G., (2006) Neuron-astrocyte interactions in the regulation of brain energy metabolism: a focus on NMR spectroscopy. J. Neurochem. 99, 393-401.
11. Fakoya F. A., (2005) Persistent neocortical astrogliosis in adult wistar rats following prenatal ethanol exposure. Brain Dev. 27, 259-265.
12. Fedele D. E., Gouder N., Guttinger M., Gabernet L., Scheurer L., Rulicke T., Crestani F., and, Boison D., (2005) Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation. Brain 128, 2383-2395.
13. Fischer C., Sanchez-Ruderisch H., and, Welzel M., et al. (2005) Galectin-1 interacts with the {alpha}5{beta}1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J. Biol. Chem. 280, 37266-37277.
14. Fuller S., Munch G., and, Steele M., (2009) Activated astrocytes: a therapeutic target in Alzheimer's disease? Expert Rev. Neurother. 9, 1585-1594.
15. Gaudet A. D., Steeves J. D., Tetzlaff W., and, Ramer M. S., (2005) Expression and functions of galectin-1 in sensory and motoneurons. Curr. Drug Targets 6, 419-425.
16. Holley J. E., Gveric D., Newcombe J., Cuzner M. L., and, Gutowski N. J., (2003) Astrocyte characterization in the multiple sclerosis glial scar. Neuropathol. Appl. Neurobiol. 29, 434-444.
17. Horie H., and, Kadoya T., (2004) Galectin-1 plays essential roles in adult mammalian nervous tissues. Roles of oxidized galectin-1. Glycoconj. J. 19, 479-489.
18. Iadecola C., Zhang F., Xu S., Casey R., and, Ross M. E., (1995) Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J. Cereb. Blood Flow Metab. 15, 378-384.
19. Ishibashi S., Kuroiwa T., Sakaguchi M., Sun L., Kadoya T., Okano H., and, Mizusawa H., (2007) Galectin-1 regulates neurogenesis in the subventricular zone and promotes functional recovery after stroke. Exp. Neurol. 207, 302-313.
20. Kajitani K., Nomaru H., and, Ifuku M., et al. (2009) Galectin-1 promotes basal and kainate-induced proliferation of neural progenitors in the dentate gyrus of adult mouse hippocampus. Cell Death Differ. 16, 417-427.
21. Kato H., Takahashi A., and, Itoyama Y., (2003) Cell cycle protein expression in proliferating microglia and astrocytes following transient global cerebral ischemia in the rat. Brain Res. Bull. 60, 215-221.
22. Kitagawa K., (2009) Anti-inflammation strategy: potential brain protection in cerebral ischemia. Nippon Yakurigaku Zasshi. 134, 202-206.
23. Koguchi K., Nakatsuji Y., Nakayama K., and, Sakoda S., (2002) Modulation of astrocyte proliferation by cyclin-dependent kinase inhibitor p27(Kip1). Glia 37, 93-104.
24. van der Leij J., van den Berg A., and, Harms G., et al. (2007) Strongly enhanced IL-10 production using stable galectin-1 homodimers. Mol. Immunol. 44, 506-513.
25. Lekishvili T., Hesketh S., Brazier M. W., and, Brown D. R., (2006) Mouse galectin-1 inhibits the toxicity of glutamate by modifying NR1 NMDA receptor expression. Eur. J. Neurosci. 24, 3017-3025.
26. Masamune A., Satoh M., Hirabayashi J., Kasai K., Satoh K., and, Shimosegawa T., (2006) Galectin-1 induces chemokine production and proliferation in pancreatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G729-G736.
27. Mazzanti M., Sul J. Y., and, Haydon P. G., (2001) Glutamate on demand: astrocytes as a ready source. Neuroscientist 7, 396-405.
28. McCarthy K. D., and, de Vellis J., (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85, 890-902.
29. Miller J. M., and, McAllister 2nd J. P., (2007) Reduction of astrogliosis and microgliosis by cerebrospinal fluid shunting in experimental hydrocephalus. Cerebrospinal Fluid Res. 4, 5.
30. Miura T., Takahashi M., Horie H., Kurushima H., Tsuchimoto D., Sakumi K., and, Nakabeppu Y., (2004) Galectin-1beta, a natural monomeric form of galectin-1 lacking its six amino-terminal residues promotes axonal regeneration but not cell death. Cell Death Differ. 11, 1076-1083.
31. Mori T., Tan J., Arendash G. W., Koyama N., Nojima Y., and, Town T., (2008) Overexpression of human S100B exacerbates brain damage and periinfarct gliosis after permanent focal ischemia. Stroke 39, 2114-2121.
32. Nakase T., Fushiki S., Sohl G., Theis M., Willecke K., and, Naus C. C., (2003) Neuroprotective role of astrocytic gap junctions in ischemic stroke. Cell Commun. Adhes. 10, 413-417.
33. Nakatsuji Y., and, Miller R. H., (2001) Density dependent modulation of cell cycle protein expression in astrocytes. J. Neurosci. Res. 66, 487-496.
34. Nomura Y., (1998) A transient brain ischemia- and bacterial endotoxin-induced glial iNOS expression and NO-induced neuronal apoptosis. Toxicol. Lett. 102-103, 65-69.
35. Okuma Y., Uehara T., Miyazaki H., Miyasaka T., and, Nomura Y., (1998) The involvement of cytokines, chemokines and inducible nitric oxide synthase (iNOS) induced by a transient ischemia in neuronal survival/death in rat brain. Nippon Yakurigaku Zasshi. 111, 37-44.
36. Pedram A., Razandi M., Hu R. M., and, Levin E. R., (1998) Astrocyte progression from G1 to S phase of the cell cycle depends upon multiple protein interaction. J. Biol. Chem. 273, 13966-13972.
37. Pekny M., and, Nilsson M., (2005) Astrocyte activation and reactive gliosis. Glia 50, 427-434.
38. Pekny M., Wilhelmsson U., Bogestal Y. R., and, Pekna M., (2007) The role of astrocytes and complement system in neural plasticity. Int. Rev. Neurobiol. 82, 95-111.
39. Qu W. S., Wang Y. H., Wang J. P., Tang Y. X., Zhang Q., Tian D. S., Yu Z. Y., Xie M. J., and, Wang W., (2010) Galectin-1 enhances astrocytic BDNF production and improves functional outcome in rats following ischemia. Neurochem. Res. 35, 1716-1724.
40. Rossi D. J., Brady J. D., and, Mohr C., (2007) Astrocyte metabolism and signaling during brain ischemia. Nat. Neurosci. 10, 1377-1386.
41. Rothwell N., (2003) Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav. Immun. 17, 152-157.
42. Sakaguchi M., Imaizumi Y., and, Okano H., (2007) Expression and function of galectin-1 in adult neural stem cells. Cell. Mol. Life Sci. 64, 1254-1258.
43. Sasaki T., Hirabayashi J., Manya H., Kasai K., and, Endo T., (2004) Galectin-1 induces astrocyte differentiation, which leads to production of brain-derived neurotrophic factor. Glycobiology 14, 357-363.
44. Sofroniew M. V., (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32, 638-647.
45. St John J. A., and, Key B., (1999) Expression of galectin-1 in the olfactory nerve pathway of rat. Brain Res. Dev. Brain Res. 117, 171-178.
46. Swanson R. A., and, Sharp F. R., (1991) Glucose and infarct size. Neurology 41, 2013.
47. Swanson R. A., Ying W., and, Kauppinen T. M., (2004) Astrocyte influences on ischemic neuronal death. Curr. Mol. Med. 4, 193-205.
48. Takemoto Y., (1993) Regional vasoconstriction and excessive grooming induced by L-arginine injection into the cisterna magna of conscious rats. Jpn. J. Physiol. 43, 389-402.
49. Takuma K., Baba A., and, Matsuda T., (2004) Astrocyte apoptosis: implications for neuroprotection. Prog. Neurobiol. 72, 111-127.
50. Tian D. S., Yu Z. Y., Xie M. J., Bu B. T., Witte O. W., and, Wang W., (2006) Suppression of astroglial scar formation and enhanced axonal regeneration associated with functional recovery in a spinal cord injury rat model by the cell cycle inhibitor olomoucine. J. Neurosci. Res. 84, 1053-1063.
51. Timmons P. M., Rigby P. W., and, Poirier F., (2002) The murine seminiferous epithelial cycle is pre-figured in the Sertoli cells of the embryonic testis. Development 129, 635-647.
52. Topp K. S., Faddis B. T., and, Vijayan V. K., (1989) Trauma-induced proliferation of astrocytes in the brains of young and aged rats. Glia 2, 201-211.
53. Trendelenburg G., and, Dirnagl U., (2005) Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 50, 307-320.
54. Tsubokawa T., Jadhav V., Solaroglu I., Shiokawa Y., Konishi Y., and, Zhang J. H., (2007) Lecithinized superoxide dismutase improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Stroke 38, 1057-1062.
55. van den Tweel E. R., Peeters-Scholte C. M., van Bel F., Heijnen C. J., and, Groenendaal F., (2002) Inhibition of nNOS and iNOS following hypoxia-ischaemia improves long-term outcome but does not influence the inflammatory response in the neonatal rat brain. Dev. Neurosci. 24, 389-395.
56. Wang W., Bu B., Xie M., Zhang M., Yu Z., and, Tao D., (2009) Neural cell cycle dysregulation and central nervous system diseases. Prog. Neurobiol. 89, 1-17.
57. Xie M., Wang W., Kimelberg H. K., and, Zhou M., (2008) Oxygen and glucose deprivation-induced changes in astrocyte membrane potential and their underlying mechanisms in acute rat hippocampal slices. J. Cereb. Blood Flow Metab. 28, 456-467.
58. Yang S., Bhardwaj A., Cheng J., Alkayed N. J., Hurn P. D., and, Kirsch J. R., (2007) Sigma receptor agonists provide neuroprotection in vitro by preserving bcl-2. Anesth. Analg. 104, 1179-1184. tables of contents.
59. Zhu Z., Zhang Q., Yu Z., Zhang L., Tian D., Zhu S., Bu B., Xie M., and, Wang W., (2007) Inhibiting cell cycle progression reduces reactive astrogliosis initiated by scratch injury in vitro and by cerebral ischemia in vivo. Glia 55, 546-558.